Katrina K. Bakken

Also affiliated with WinnMed, Mayo Clinic in Arizona, Mayo Clinic Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway Deficits”.

DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway Deficits

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0003

N/A

0.467DataRank · unranked

12 citations

Emily J. Smith, Michael S. Regan, Sylwia A. Stopka, Gerard Baquer, Zhiyi Xue +19 more

The novel brain penetrant ataxia-telangiectasia mutated inhibitor WSD0628 provides robust radiosensitization of brain tumor patient-derived xenografts

Neuro-Oncology(2025)10.1093/neuonc/noaf102

N/A

0.312DataRank · unranked

7 citations

Ann C. Mladek, Sneha Rathi, Sonia Jain, Rachael A. Vaubel, Lateef A Odukoya +17 more

WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad066

N/A

0.269DataRank · unranked

5 citations

Sylwia A. Stopka, Ju‐Hee Oh, Ann C. Mladek, Danielle M. Burgenske, Michael S. Regan +15 more

Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0664

N/A

0.241DataRank · unranked

4 citations

Sneha Rathi, Margaret A. Connors, Michael P. Grams, Rachael A. Vaubel, Katrina K. Bakken +13 more

Quantitative analysis of tyrosine phosphorylation from FFPE tissues reveals patient specific signaling networks

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.10.291922

N/A

0.184DataRank · unranked

2 citations

Danielle M. Burgenske, Ann C. Mladek, Katrina K. Bakken, Jenevieve Kuang, Judy C. Boughey +7 more

Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0244

N/A

0.165DataRank · unranked

2 citations

Wenjuan Zhang, Ju-Hee Oh, Ann C. Mladek, Tugce I. Pasa, Jennifer Gantchev +24 more

Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0552

N/A

0DataRank · unranked

12 citations

Sonja Dragojevic, Cameron M. Callaghan, Emily J. Smith, Surabhi Talele, Wenjuan Zhang +15 more

Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac130

N/A

0DataRank · unranked

13 citations

Michael S. Regan, Jessica I. Griffith, Sonia Jain, Sylwia A. Stopka, Danielle M. Burgenske +19 more

RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma

Neuro-Oncology(2022)10.1093/neuonc/noac051

N/A

0DataRank · unranked

27 citations

Huihuang Yan, Shulan Tian, Paul A. Decker, Danielle M. Burgenske, Katrina K. Bakken +11 more

PK-PD-efficacy modeling of brigimadlin in MDM2-amplified glioblastoma.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2071

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Danielle M. Burgenske, Katie L. Waller, Paul A. Decker, Matt Kosel +13 more

Pre-clinical modeling of navtemadlin pharmacokinetics (PK), pharmacodynamics (PD), and efficacy in glioblastoma, IDH-wildtype.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2012

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Ann C. Mladek, Tugce I. Pasa, Katie L. Waller, Sylwia A. Stopka +15 more

Factors Influencing the Central Nervous System (CNS) Distribution of the Ataxia Telangiectasia Mutated and Rad3-Related Inhibitor Elimusertib (BAY1895344): Implications for the Treatment of CNS Tumors

Journal of Pharmacology and Experimental Therapeutics(2024)10.1124/jpet.123.002002

N/A

0DataRank · unranked

0 citations

Ann C. Mladek, Ju‐Hee Oh, Sonja Dragojevic, Danielle M. Burgenske, Wenjuan Zhang +10 more

The impact of therapeutic radiation on drug distribution across the blood-brain barrier in normal mouse brain and orthotopic glioblastoma tumors

Neuro-Oncology(2025)10.1093/neuonc/noaf093

N/A

0DataRank · unranked

4 citations

Michael P. Grams, Rajneet K. Oberoi, Ju‐Hee Oh, Paul A. Decker, Terence T. Sio +12 more

Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0426

N/A

0DataRank · unranked

30 citations

Jessica I. Griffith, Kendra A. Porath, Sneha Rathi, Jiayan Le, Tugce I. Pasa +14 more

Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf259

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Nishika Karbhari, Ju-Hee Oh, Katie L. Waller, Ann C. Mladek +16 more